Over the past 12 months, information about the SARS-CoV-2 virus (or COVID-19 as it is commonly known) continues to emerge. A wealth of information appears on the website of the U.S. Centers for Disease Control and Prevention (2021) about the virus, management, vaccines, quarantine, and new variants. A search of the National Library of Medicine’s (NLM) National Center for Biotechnology Information’s database (PubMed) identified over 90,000 COVID-19 related articles already in print from around the world (NLM, 2021). Approximately 800 clinical trials examining a variety of biologics for COVID-19 intervention are also underway (all phases) worldwide (NLM ClinicalTrials.gov, 2021).
The role of audiology in the management of COVID-19 patients has emerged as survivors begin to experience a continuance of their health issues post-discharge or a late onset of medical problems. This group of patients has been referred to as COVID-19 “long-haulers.” COVID-19 survivors may also experience auditory/vestibular problems. DiSogra (2020) addresses this issue in detail and offers suggestions for ongoing monitoring.
This article will address whether COVID-19 can be found in cerumen and what precautions need to be taken with current patients and ‘long-haulers.’
Recent Posts
Academy Files Rulemaking Petition to Restore ABA Language in VA Regulations
Earlier last year, the Virginia Board of Audiology and Speech-Language Pathology finalized regulatory changes intended to streamline licensure by removing direct ties between certification and…
Congress Needs to Hear From Audiologists on Student Loan Access
The Professional Student Degree Act, H.R. 6718, introduced by Representative Michael Lawler (R-NY), was introduced in mid-December. This bill reaffirms audiology’s status as a professional…
Why Wild Animals Don’t Have Floppy Ears
In 1959, a scientist began a domestication experiment with silver foxes. Critics believed the experiment was, at the very least, too ambitious (if not outright…


